Shiro Miyayama

7.5k total citations · 2 hit papers
140 papers, 5.1k citations indexed

About

Shiro Miyayama is a scholar working on Hepatology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shiro Miyayama has authored 140 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Hepatology, 79 papers in Surgery and 43 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shiro Miyayama's work include Hepatocellular Carcinoma Treatment and Prognosis (76 papers), Liver Disease and Transplantation (35 papers) and Liver Disease Diagnosis and Treatment (28 papers). Shiro Miyayama is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (76 papers), Liver Disease and Transplantation (35 papers) and Liver Disease Diagnosis and Treatment (28 papers). Shiro Miyayama collaborates with scholars based in Japan, South Korea and United Kingdom. Shiro Miyayama's co-authors include Osamu Matsui, Masashi Yamashiro, Toshifumi Gabata, Yoh Zen, Yasuni Nakanuma, Dai Inoue, Nobuyoshi Tanaka, Tetsuya Minami, Tsutomu Takashima and Kazuo Notsumata and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Radiology.

In The Last Decade

Shiro Miyayama

134 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan

2014 456 citations Masatoshi Kudo, Osamu Matsui et al. profile →
A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements

2020 194 citations Masatoshi Kudo, Masafumi Ikeda et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shiro Miyayama Japan	36	3.1k	2.0k	1.8k	1.1k	853	140	5.1k
Jae Ho Byun South Korea	37	1.8k 0.6×	1.7k 0.8×	2.1k 1.1×	839 0.7×	412 0.5×	175	4.7k
Irene Bargellini Italy	30	2.0k 0.6×	921 0.5×	934 0.5×	1.1k 0.9×	147 0.2×	99	3.2k
Luigi Grazioli Italy	39	2.9k 0.9×	1.5k 0.7×	1.7k 1.0×	766 0.7×	133 0.2×	129	4.7k
S Wallace United States	41	939 0.3×	1.8k 0.9×	783 0.4×	2.0k 1.7×	576 0.7×	157	4.7k
Katerina Malagari Greece	27	1.5k 0.5×	815 0.4×	809 0.4×	1.5k 1.3×	148 0.2×	101	3.3k
Michel Rivoire France	32	1.3k 0.4×	2.3k 1.1×	741 0.4×	1.4k 1.2×	196 0.2×	191	4.9k
Atsuhiro Nakatsuka Japan	34	1.6k 0.5×	1.3k 0.7×	616 0.3×	1.6k 1.4×	106 0.1×	110	3.4k
Hwan Jun Jae South Korea	33	1.3k 0.4×	2.0k 1.0×	491 0.3×	968 0.8×	200 0.2×	149	3.5k
Kumaresan Sandrasegaran United States	39	542 0.2×	2.2k 1.1×	874 0.5×	964 0.8×	302 0.4×	120	4.2k
José Ignacio Bilbao Spain	35	3.7k 1.2×	2.0k 1.0×	1.7k 0.9×	1.3k 1.1×	57 0.1×	146	4.9k

Countries citing papers authored by Shiro Miyayama

Since Specialization

Citations

This map shows the geographic impact of Shiro Miyayama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiro Miyayama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiro Miyayama more than expected).

Fields of papers citing papers by Shiro Miyayama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiro Miyayama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiro Miyayama. The network helps show where Shiro Miyayama may publish in the future.

Co-authorship network of co-authors of Shiro Miyayama

This figure shows the co-authorship network connecting the top 25 collaborators of Shiro Miyayama. A scholar is included among the top collaborators of Shiro Miyayama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiro Miyayama. Shiro Miyayama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Miyayama, Shiro. (2025). Efficacy of cone-beam computed tomography and guidance software in transarterial chemoembolization for hepatocellular carcinoma. SHILAP Revista de lepidopterología. 2(2). 100075–100075.

Kim, Hyo‐Cheol, Shiro Miyayama, Edward Lee, et al.. (2024). Interventional Radiology for Bleeding Ectopic Varices: Individualized Approach Based on Vascular Anatomy. Radiographics. 44(8). e230140–e230140. 2 indexed citations

Mendiratta‐Lala, Mishal, Anum Aslam, Julius Chapiro, et al.. (2023). Ethiodized oil as an imaging biomarker after conventional transarterial chemoembolization. European Radiology. 34(5). 3284–3297. 3 indexed citations

Kim, Hyo‐Cheol, Shiro Miyayama, Jin Woo Choi, Gyoung Min Kim, & Jin Wook Chung. (2022). Hepatocellular Carcinoma Supplied by the Inferior Phrenic Artery or Cystic Artery: Anatomic and Technical Considerations. Radiographics. 43(1). e220076–e220076. 13 indexed citations

Kudo, Masatoshi, Masafumi Ikeda, Kazuomi Ueshima, et al.. (2022). Response Evaluation Criteria in Cancer of the liver version 6 (Response Evaluation Criteria in Cancer of the Liver 2021 revised version). Hepatology Research. 52(4). 329–336. 12 indexed citations

Kim, Hyo‐Cheol, Shiro Miyayama, & Jin Wook Chung. (2019). Selective Chemoembolization of Caudate Lobe Hepatocellular Carcinoma: Anatomy and Procedural Techniques. Radiographics. 39(1). 289–302. 17 indexed citations

Yoshida, Kotaro, Osamu Matsui, Shiro Miyayama, et al.. (2018). Isolated Arteries Originating from the Intrahepatic Arteries: Anatomy, Function, and Importance in Intervention. Journal of Vascular and Interventional Radiology. 29(4). 531–537.e1. 23 indexed citations

Miyayama, Shiro, et al.. (2015). Ruptured Pancreaticoduodenal Artery Aneurysm Associated with Median Arcuate Ligament Compression and Aortic Dissection Successfully Treated with Embolotherapy. Annals of Vascular Diseases. 8(1). 40–42. 11 indexed citations

Kudo, Masatoshi, Osamu Matsui, Namiki Izumi, et al.. (2014). Transarterial Chemoembolization Failure/Refractoriness: JSH-LCSGJ Criteria 2014 Update. Oncology. 87(Suppl. 1). 22–31. 205 indexed citations

10.

Yamakado, Koichiro, Shiro Miyayama, Shozo Hirota, et al.. (2014). Prognosis of patients with intermediate-stage hepatocellular carcinomas based on the Child-Pugh score: subclassifying the intermediate stage (Barcelona Clinic Liver Cancer stage B). Japanese Journal of Radiology. 32(11). 644–649. 35 indexed citations

11.

Miyayama, Shiro, et al.. (2012). A case of gigantic solitary fibrous tumor (sft) in the pelvic cavity arising from the mesenterium. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 73(2). 406–410. 2 indexed citations

12.

Miyayama, Shiro, et al.. (2012). Clinical features of hepatocellular carcinoma supplied by the left internal mammary artery. Japanese Journal of Radiology. 30(10). 798–805. 3 indexed citations

13.

Notsumata, Kazuo, Hiroyuki Watanabe, Daishu Toya, et al.. (2010). The efficacy of ezetimibe add-on with combination peginterferon plus ribavirin therapy in patients with chronic hepatitis C. Kanzo. 51(11). 607–614. 1 indexed citations

14.

Miyayama, Shiro, Masashi Yamashiro, Miho Okuda, et al.. (2010). Detection of Corona Enhancement of Hypervascular Hepatocellular Carcinoma by C-Arm Dual-Phase Cone-Beam CT During Hepatic Arteriography. CardioVascular and Interventional Radiology. 34(1). 81–86. 57 indexed citations

15.

Miyayama, Shiro, et al.. (2009). Anastomosis between the hepatic artery and the extrahepatic collateral or between extrahepatic collaterals: Observation on angiography. Journal of Medical Imaging and Radiation Oncology. 53(3). 271–282. 19 indexed citations

16.

Okuda, Miho, Shiro Miyayama, Masashi Yamashiro, et al.. (2009). Sloughing of Intraductal Tumor Thrombus of Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization. CardioVascular and Interventional Radiology. 33(3). 619–623. 10 indexed citations

17.

Miyayama, Shiro, Osamu Matsui, Toru Yamamoto, et al.. (2003). Abdominal Aortic Aneurysm with a Dilated Common Iliac Artery: Treatment Using a Handmade Bifurcated Stent-Graft with a Wide Iliac Limb End. CardioVascular and Interventional Radiology. 26(6). 511–5. 3 indexed citations

18.

Miyayama, Shiro, Osamu Matsui, Tetsuya Minami, et al.. (2003). Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma Fed by the Cystic Artery. Journal of Vascular and Interventional Radiology. 14(9). 1155–1161. 40 indexed citations

19.

Kasahara, Yoshio, et al.. (1996). A CASE OF MESENTERIC LIPOBLASTOMA IN A 7-MONTH OLD BOY. The journal of the Japanese Practical Surgeon Society. 57(9). 2273–2277.

20.

Miyayama, Shiro, et al.. (1995). Septic Pulmonary Emboli Secondary to Pyogenic Liver Abscess in a Diabetic Patient.. Internal Medicine. 34(1). 42–45. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact